PG Blain

656 total citations
18 papers, 519 citations indexed

About

PG Blain is a scholar working on Pharmacology, Plant Science and Pharmacology. According to data from OpenAlex, PG Blain has authored 18 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Plant Science and 3 papers in Pharmacology. Recurrent topics in PG Blain's work include Pesticide Exposure and Toxicity (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Carcinogens and Genotoxicity Assessment (2 papers). PG Blain is often cited by papers focused on Pesticide Exposure and Toxicity (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Carcinogens and Genotoxicity Assessment (2 papers). PG Blain collaborates with scholars based in United Kingdom, United States and Lebanon. PG Blain's co-authors include Faith M. Williams, Nigel McCracken, D. Nicholas Bateman, R Gokal, JC Mucklow, PA Routledge, DG Shand, J C Mucklow, M. D. Rawlins and E Mutch and has published in prestigious journals such as Biochemical Pharmacology, Epidemiology and Clinical Pharmacokinetics.

In The Last Decade

PG Blain

17 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
PG Blain United Kingdom 12 111 108 94 81 78 18 519
Faith M. Williams United Kingdom 13 102 0.9× 109 1.0× 42 0.4× 26 0.3× 62 0.8× 19 536
Srikumaran Melethil United States 15 44 0.4× 60 0.6× 62 0.7× 75 0.9× 81 1.0× 40 485
K Hrubý Austria 11 32 0.3× 221 2.0× 109 1.2× 35 0.4× 68 0.9× 71 573
F Perlı́k Czechia 17 108 1.0× 165 1.5× 126 1.3× 25 0.3× 148 1.9× 71 791
D. Kadar Canada 15 125 1.1× 293 2.7× 130 1.4× 18 0.2× 148 1.9× 29 729
Kuang‐Chih Hsiao Australia 12 70 0.6× 311 2.9× 149 1.6× 24 0.3× 72 0.9× 28 755
Adnan El‐Yazigi Saudi Arabia 15 64 0.6× 72 0.7× 94 1.0× 15 0.2× 110 1.4× 60 597
B.H. Thomas United Kingdom 13 32 0.3× 185 1.7× 108 1.1× 47 0.6× 77 1.0× 53 502
R. S. Addison Australia 15 110 1.0× 79 0.7× 88 0.9× 16 0.2× 52 0.7× 26 663
Marie‐Madeleine Galteau France 16 58 0.5× 106 1.0× 252 2.7× 24 0.3× 71 0.9× 28 869

Countries citing papers authored by PG Blain

Since Specialization
Citations

This map shows the geographic impact of PG Blain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by PG Blain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites PG Blain more than expected).

Fields of papers citing papers by PG Blain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by PG Blain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by PG Blain. The network helps show where PG Blain may publish in the future.

Co-authorship network of co-authors of PG Blain

This figure shows the co-authorship network connecting the top 25 collaborators of PG Blain. A scholar is included among the top collaborators of PG Blain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with PG Blain. PG Blain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Blain, PG. (2003). Treatment of poisoning by selected chemical compounds. 1 indexed citations
2.
Mutch, E, et al.. (2000). Cytogenetic response without changes in peripheral cholinesterase enzymes following exposure to a sheep dip containing diazinon in vivo and in vitro. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 472(1-2). 85–92. 38 indexed citations
3.
Kingham, Simon, C E Dunn, C. Foy, et al.. (1998). HEALTH IN THE VICINITY OF A WALLPAPER FACTORY. Epidemiology. 9(Supplement). S33–S33. 2 indexed citations
4.
Williams, Faith M., et al.. (1997). The effects of multiple low doses of organophosphates on target enzymes in brain and diaphragm in the mouse. Human & Experimental Toxicology. 16(2). 67–71. 10 indexed citations
5.
Blain, PG, et al.. (1997). An investigation into the role of rat skeletal muscle as a site for xenobiotic metabolism using microsomes and isolated cells. Human & Experimental Toxicology. 16(3). 138–145. 14 indexed citations
6.
Blain, PG, et al.. (1997). Metabolism of n-hexane by rat liver and extrahepatic tissues and the effect of cytochrome P-450 inducers. Human & Experimental Toxicology. 16(3). 131–137. 18 indexed citations
7.
Upshall, D. G., et al.. (1996). The effect of sulphur mustard on glutathione levels in rat lung slices and the influence of treatment with arylthiols and cysteine esters. Human & Experimental Toxicology. 15(8). 619–624. 18 indexed citations
8.
Elliott, C. Gregory, et al.. (1994). The effects of a peripherally selective alpha 2‐adrenoceptor antagonist, MK‐467, on the metabolic and cardiovascular response to exercise in healthy man.. British Journal of Clinical Pharmacology. 37(1). 39–44. 10 indexed citations
9.
McCracken, Nigel, PG Blain, & Faith M. Williams. (1993). Nature and role of xenobiotic metabolizing esterases in rat liver, lung, skin and blood. Biochemical Pharmacology. 45(1). 31–36. 78 indexed citations
10.
Williams, Faith M., Elaine Mutch, & PG Blain. (1993). Paraoxonase distribution in caucasian males. Chemico-Biological Interactions. 87(1-3). 155–160. 5 indexed citations
11.
Moore, U., R. A. Seymour, E Mutch, et al.. (1989). Benorylate hydrolysis by human plasma and human liver.. British Journal of Clinical Pharmacology. 28(6). 703–708. 12 indexed citations
12.
Bateman, D. Nicholas, PG Blain, K. W. Woodhouse, et al.. (1985). Pharmacokinetics and Clinical Toxicity of Quinine Overdosage: Lack of Efficacy of Techniques Intended to Enhance Elimination. QJM. 54(214). 125–31. 52 indexed citations
13.
Blain, PG, et al.. (1985). Determinants of plasma alpha 1‐acid glycoprotein (AAG) concentrations in health.. British Journal of Clinical Pharmacology. 20(5). 500–502. 64 indexed citations
14.
Blain, PG. (1984). ADVERSE EFFECTS OF DRUGS ON SKELETAL MUSCLE. Adverse Drug Reaction Bulletin. 104(1). 384–387. 1 indexed citations
15.
Grasela, Thaddeus H., Lewis B. Sheiner, B. Rambeck, et al.. (1983). Steady-state Pharmacokinetics of Phenytoin from Routinely Collected Patient Data???. Clinical Pharmacokinetics. 8(4). 355–364. 90 indexed citations
16.
Blain, PG, et al.. (1982). Family study of antipyrine clearance.. BMJ. 284(6310). 150–152. 20 indexed citations
17.
Bateman, D. Nicholas, et al.. (1981). The pharmacokinetics of single doses of metoclopramide in renal failure. European Journal of Clinical Pharmacology. 19(6). 437–441. 66 indexed citations
18.
Blain, PG, et al.. (1981). Pharmacokinetics of phenytoin in children.. British Journal of Clinical Pharmacology. 12(5). 659–661. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026